SPONSOR
Rigel Pharmaceuticals
Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: NSCLC (Non-small Cell Lung Cancer)Thyroid CancerSolid Tumor MalignanciesAdvanced Malignancies
Rigel Pharmaceuticals is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced Malignancies.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Rigel Pharmaceuticals
How many clinical trials has Rigel Pharmaceuticals sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Rigel Pharmaceuticals, of which 1 are actively recruiting participants. These trials cover conditions including NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rigel Pharmaceuticals research focus on?
Rigel Pharmaceuticals clinical trials span NSCLC (Non-small Cell Lung Cancer), Thyroid Cancer, Solid Tumor Malignancies, Advanced Malignancies. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rigel Pharmaceuticals clinical trial?
To participate in a Rigel Pharmaceuticals trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rigel Pharmaceuticals trials with current recruitment status updated daily.
Clinical Trials by Rigel Pharmaceuticals
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology